What to do for a nose bleed while taking aspirin (acetylsalicylic acid) and Plavix (clopidogrel)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Nose Bleed While Taking Aspirin and Plavix

For a nose bleed while taking aspirin and clopidogrel (Plavix), apply firm sustained compression to the lower third of the nose for 10-15 minutes as first-line treatment, and if bleeding persists, temporarily discontinue one antiplatelet agent (preferably clopidogrel) after consulting with your cardiologist. 1

Initial Management Steps

  1. Apply direct pressure:

    • Pinch the soft part of the nose (lower third) firmly for 10-15 minutes without releasing 1
    • Lean forward slightly to prevent blood from flowing down the throat
    • Breathe through the mouth during compression
  2. Use vasoconstrictor spray (if available):

    • Apply oxymetazoline (Afrin) or similar nasal decongestant spray 2
    • This can help constrict blood vessels and slow bleeding
  3. Apply ice pack:

    • Place cold compress or ice pack over the bridge of the nose
    • This promotes vasoconstriction and helps slow bleeding

If Bleeding Persists After Initial Measures

  1. Seek medical attention if bleeding doesn't stop after 15-20 minutes of compression 1

  2. Antiplatelet management:

    • For patients on dual antiplatelet therapy with persistent bleeding, consider temporary discontinuation of one agent (preferably clopidogrel) 2, 1
    • This decision should be made in consultation with the prescribing physician, as premature discontinuation increases risk of cardiovascular events 3
  3. Medical interventions:

    • Cauterization: If a specific bleeding site can be identified, cauterization is preferred over nasal packing 2, 1
    • Topical tranexamic acid: May be effective in controlling epistaxis in patients on antiplatelet therapy 2, 4
    • Nasal packing: May be necessary if bleeding cannot be controlled by other methods 2

Warning Signs Requiring Immediate Medical Attention

  • Excessive blood loss leading to lightheadedness or dizziness
  • Blood in vomit or stool
  • Inability to control bleeding after 20 minutes of direct pressure
  • Difficulty breathing
  • Pale skin or cold extremities 1

Prevention of Recurrence

  1. Nasal moisturization:

    • Apply saline nasal spray or gel 1-3 times daily 1
    • Use petroleum jelly inside the nostrils (sparingly)
  2. Environmental modifications:

    • Use a humidifier in dry environments 1
    • Avoid excessive heat that can dry nasal passages
  3. Behavioral modifications:

    • Avoid nose picking and vigorous nose blowing 1
    • Avoid hot and spicy foods that can dilate blood vessels

Important Considerations for Patients on Antiplatelet Therapy

  • Patients on antiplatelet therapy like aspirin and clopidogrel have increased risk of severe epistaxis 5
  • Never stop both antiplatelet medications simultaneously without medical consultation 3
  • If temporary discontinuation is necessary, clopidogrel is typically stopped first while continuing aspirin 2
  • Resumption of antiplatelet therapy should occur as soon as bleeding is controlled 2
  • Patients with recurrent epistaxis while on dual antiplatelet therapy may need evaluation for alternative antiplatelet regimens 1

When to Return to Antiplatelet Therapy

  • Resume antiplatelet therapy as soon as bleeding has been controlled for 24-48 hours
  • If you've had severe or recurrent epistaxis, consult with both your cardiologist and ENT specialist before resuming full antiplatelet therapy 2
  • Consider a step-wise approach, resuming one medication first (typically aspirin) followed by the second agent after ensuring no recurrent bleeding 2

Remember that while epistaxis can be concerning, the cardiovascular protection provided by antiplatelet therapy is crucial, and decisions about medication changes should always involve your healthcare provider.

References

Guideline

Epistaxis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tranexamic acid for patients with nasal haemorrhage (epistaxis).

The Cochrane database of systematic reviews, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.